Biotech Analysts hold a conference call with management on October 1 at 11 am hosted by JPMorgan.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KYMR:
- Kymera Therapeutics price target raised to $63 from $53 at Oppenheimer
- Kymera Therapeutics price target raised to $68 from $53 at Truist
- Kymera Therapeutics price target raised to $70 from $60 at H.C. Wainwright
- Kymera Therapeutics: Promising Developments and Buy Rating Amidst Significant Clinical Advancements
- Kymera Therapeutics to present on KT-621 at EADV Congress